A Dose-exploration Study of EDP167 in HoFH

Abroad (travel likely)RecruitingPHASE2

Conditions

Homozygous Familial Hypercholesterolemia (HoFH)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fuwai Hospital, Beijing, China
Contact: Study coordinator (Ethics Committee of Fuwai Hospital) · +86 010 88396281

Study leads

Kefei Dou, MD
Principal Investigator
Chinese Academy of Medical Sciences, Fuwai Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias

Cardiovascular · Metabolic Disease · Dyslipidemias

Abroad (travel likely)RecruitingPHASE1

Jacksonville, United States · Orlando, United States

Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

Homozygous Familial Hypercholesterolemia (HoFH) · Coronary Computed Tomography Angiography

Abroad (travel likely)Recruiting

Paris, France · Caserta, Italy

The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository

Homozygous Familial Hypercholesterolemia

Abroad (travel likely)Recruiting

New York, United States

The ORIGIN-FH Study

Heterozygous Familial Hypercholesterolemia (HeFH) · Homozygous Familial Hypercholesterolemia (HoFH) · Familial Hypercholesterolemia

Abroad (travel likely)Recruiting

Madison, United States